Published in N Engl J Med on March 14, 1996
Adolescent HIV testing--who says who signs? Am J Public Health (1997) 0.75
Physicians' experience and survival in patients with AIDS. N Engl J Med (1996) 0.75
Physicians' experience and survival in patients with AIDS. N Engl J Med (1996) 0.75
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 13.84
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 8.52
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA (1997) 6.35
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA (1996) 5.29
HIV viral load markers in clinical practice. Nat Med (1996) 4.78
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group. N Engl J Med (1992) 4.71
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA (1998) 4.61
CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann Intern Med (1993) 4.43
Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med (1984) 2.93
Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Ann Intern Med (1986) 2.53
Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. N Engl J Med (1990) 2.29
The impact of HIV on chronic kidney disease outcomes. Kidney Int (2007) 2.22
Findings in psychiatric consultations with patients with acquired immune deficiency syndrome. Am J Psychiatry (1985) 1.90
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group. JAMA (1989) 1.84
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group. N Engl J Med (1994) 1.66
Mortality associated with mode of presentation in the acquired immune deficiency syndrome. J Natl Cancer Inst (1984) 1.59
Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Infect Dis (1994) 1.55
AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA (1989) 1.48
Serological characterization of HTLV-III infection in AIDS and related disorders. J Infect Dis (1986) 1.47
The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I study. AIDS (1990) 1.44
Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol (1996) 1.43
HIV, HTLV-I, and CD4+ lymphocytes. Troubles in the relationship. JAMA (1994) 1.42
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection. Ann Intern Med (1993) 1.42
The clinical spectrum of the acquired immunodeficiency syndrome: implications for comprehensive patient care. Ann Intern Med (1985) 1.26
Treatment of patients with acquired immunodeficiency syndrome and associated manifestations. JAMA (1987) 1.21
Preferences of homosexual men with AIDS for life-sustaining treatment. N Engl J Med (1986) 1.19
Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia. Ann Intern Med (1986) 1.19
Intestinal infection with Mycobacterium avium in acquired immune deficiency syndrome (AIDS). Histological and clinical comparison with Whipple's disease. Dig Dis Sci (1985) 1.19
Ethical dilemmas in caring for patients with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.08
Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.06
Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine. J Infect Dis (1989) 1.01
Significant changes in HIV antigen level in the serum of patients treated with azidothymidine. N Engl J Med (1986) 0.99
Hematologic manifestations in homosexual men with Kaposi's sarcoma. Am J Clin Pathol (1984) 0.92
Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr (1988) 0.90
Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complex. Antimicrob Agents Chemother (1991) 0.88
Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study. Cancer Treat Rep (1980) 0.88
Routine care and psychosocial support of the patient with the acquired immunodeficiency syndrome. Med Clin North Am (1986) 0.86
Red cell transfusion therapy for anemia in patients with AIDS and ARC: incidence, associated factors, and outcome. Transfusion (1990) 0.84
Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group. JAMA (1987) 0.84
Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group. Arch Intern Med (1992) 0.83
Toward a definition of HIV expertise: a survey of experienced HIV physicians. AIDS Patient Care STDS (2001) 0.83
Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. Semin Oncol (1987) 0.83
Controversies in the management of HIV-related illnesses. J Gen Intern Med (1991) 0.82
Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Immunother (1991) (1991) 0.81
Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 0.81
Therapy of liver tumors metastatic from colorectal cancer with whole-liver radiation combined with 5-FU, adriamycin, and methotrexate. Cancer Chemother Pharmacol (1982) 0.80
HIV antigen variability in ARC/AIDS. J Acquir Immune Defic Syndr (1991) 0.80
Pharmacokinetics of GLQ223 in rats, monkeys, and patients with AIDS or AIDS-related complex. Antimicrob Agents Chemother (1991) 0.80
Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. Semin Oncol (1986) 0.80
HIV-1 protease inhibitors. AIDS Clin Rev (1997) 0.80
Treatment of Kaposi's sarcoma with interferon alfa-2b (Intron A). Cancer (1987) 0.80
Therapy of hepatocellular cancer with combined intrahepatic arterial chemotherapy and whole liver irradiation. Ann Acad Med Singapore (1980) 0.80
Periodontal status of individuals in early stages of human immunodeficiency virus infection. Community Dent Oral Epidemiol (1991) 0.79
Lack of response to suramin in patients with AIDS and AIDS-related complex. Am J Med (1987) 0.79
AIDS-related benign lymphadenopathy and malignant lymphoma: clinical aspects and virologic interactions. AIDS Res (1986) 0.79
Lymphadenopathy: end-point prodrome? Update of a 36-month prospective study. Adv Exp Med Biol (1985) 0.78
Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group. J Acquir Immune Defic Syndr (1993) 0.78
Treatment of AIDS-related Kaposi's sarcoma. Hematol Oncol Clin North Am (1991) 0.78
Recombinant interferon alpha in the treatment of acquired immune deficiency syndrome-related Kaposi's sarcoma. Semin Oncol (1985) 0.78
The role of chemotherapy for epidemic Kaposi's sarcoma. Semin Oncol (1987) 0.78
Intralesional recombinant tumor necrosis factor-alpha for AIDS-associated Kaposi's sarcoma: a randomized, double-blind trial. J Acquir Immune Defic Syndr (1989) 0.77
Lymphadenopathy: endpoint or prodrome? Update of a 24-month prospective study. Ann N Y Acad Sci (1984) 0.77
Kaposi's sarcoma and the acquired immunodeficiency syndrome. Med Clin North Am (1986) 0.77
Oral manifestations of tumor and opportunistic infections in the acquired immunodeficiency syndrome (AIDS): findings in 53 homosexual men with Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol (1983) 0.76
A phase I/II study of recombinant tumor necrosis factor and recombinant interferon gamma in patients with AIDS-related complex. Biotechnol Ther (1993) 0.76
Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II trial. J Acquir Immune Defic Syndr (1991) 0.76
Epidemiology and the human immunodeficiency virus. Clinical effects of intravenous drug misuse. JAMA (1992) 0.75
Drug level monitoring in a double-blind multicenter trial: false-positive zidovudine measurements in AIDS clinical trials group protocol 019. Antimicrob Agents Chemother (1991) 0.75
Medicine and HIV. Interview by David Frankel. Lancet (1996) 0.75
Intermittent therapy. J Acquir Immune Defic Syndr (1994) 0.75
Disseminated Kaposi's sarcoma in male homosexuals. J Am Podiatry Assoc (1983) 0.75
HIV expertise: a roundtable. AIDS Clin Care (2001) 0.75
Failure of isotretinoin in Kaposi's sarcoma. Lancet (1984) 0.75
The problem of Kaposi's sarcoma in AIDS. Front Radiat Ther Oncol (1985) 0.75
The AIDS epidemic: continental drift. Nature (1984) 0.75
Moving towards a uniform staging for human immunodeficiency virus-associated Kaposi's sarcoma. J Clin Oncol (1989) 0.75
Failure (and danger) of mitozantrone in AIDS-related Kaposi's sarcoma. Lancet (1985) 0.75
Isolated thrombocytopenia in homosexual men--longitudinal follow-up. Adv Exp Med Biol (1985) 0.75
Interferon and interleukin-2 therapy of Kaposi's sarcoma. Adv Exp Med Biol (1985) 0.75
A phase I study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus (HIV) p17 synthetic peptide analogue sub-unit vaccine in seronegative subjects. AIDS Res Hum Retroviruses (1992) 0.75
From the Institute of Medicine. JAMA (1994) 0.75
Providing clinical pharmacy services in an AIDS--oncology ambulatory-care clinic. Am J Hosp Pharm (1988) 0.75